Compare iShares MSCI South Africa ETF (EZA) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI South Africa ETF vs Inovio Pharmaceuticals Inc — how do they compare? iShares MSCI South Africa ETF trades at $68.53, while Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M). The key difference: iShares MSCI South Africa ETF is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| EZA | INO | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $81.60 | $2.87 |
52-Week Low | $56.57 | $0.66 |
Market Cap | — | $78.55M |
Enterprise Value | — | $49.56M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EZA trades at $68.43, down 1.86% with technical indicators showing mixed signals. The stock maintains bullish moving averages but faces overbought conditions with RSI readings above 70. Recent dividend declaration of $1.43 for H1-2026 provides income appeal, though fundamental metrics remain undisclosed in current data.
South African market exposure presents both opportunity and risk given current macroeconomic pressures on financials and commodities. The ETF's heavy weighting in gold, banking, and platinum group metals faces headwinds from global reflation trends, requiring careful monitoring of constituent performance.
INO trades at $0.772, up 4.83% in the last 24 hours, but technical indicators signal a bearish trend. The company shows minimal revenue of $65,340 in 2025 with a net loss of $84.95 million, though it has beaten EPS estimates in recent quarters. Key developments include an upcoming Q2 2026 earnings report on August 12, 2026, and a pending FDA decision on INO-3107 by October 30, 2026.
The outlook hinges on FDA approval of INO-3107, with a consensus price target of $3.25 implying significant upside. However, high cash burn, negative margins, and legal scrutiny pose substantial risks. Investors should weigh the binary event against persistent financial challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares MSCI South Africa ETF
EZA is a country-specific ETF that tracks the South African equity market. It provides exposure to large and mid-cap companies across key sectors like materials and financials, with top holdings such as AngloGold Ashanti and Naspers.
Read more on EZA →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
